152 related articles for article (PubMed ID: 21305610)
21. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Zai CC; Romano-Silva MA; Hwang R; Zai GC; Deluca V; Müller DJ; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
Schizophr Res; 2008 Dec; 106(2-3):248-52. PubMed ID: 18838251
[TBL] [Abstract][Full Text] [Related]
22. Re: Klintenberg et al, tardive dyskinesia model in the common marmoset.
Friedman JH
Mov Disord; 2003 Jan; 18(1):114-5. PubMed ID: 12518311
[No Abstract] [Full Text] [Related]
23. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.
Alptekin K; Kivircik BB
Int Clin Psychopharmacol; 2002 Sep; 17(5):263-4. PubMed ID: 12177588
[TBL] [Abstract][Full Text] [Related]
24. Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.
Souza RP; de Luca V; Remington G; Lieberman JA; Meltzer HY; Kennedy JL; Wong AH
Psychopharmacology (Berl); 2010 Jun; 210(3):347-54. PubMed ID: 20369355
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
26. Clozapine-induced tardive dyskinesia: a case report.
Ertugrul A; Demir B
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
[TBL] [Abstract][Full Text] [Related]
27. Clozapine for tardive dyskinesia in adolescents.
Levkovitch Y; Kronenberg J; Kayser N; Zvyagelski M; Gaoni B; Gadoth N
Brain Dev; 1995; 17(3):213-5. PubMed ID: 7573764
[TBL] [Abstract][Full Text] [Related]
28. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
Chong SA; Tan EC; Tan CH; Mythily ; Chan YH
Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):51-4. PubMed ID: 12497614
[TBL] [Abstract][Full Text] [Related]
30. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
[TBL] [Abstract][Full Text] [Related]
31. Tardive oculogyric crisis during treatment with clozapine: report of three cases.
Uzun O; Doruk A
Clin Drug Investig; 2007; 27(12):861-4. PubMed ID: 18020545
[TBL] [Abstract][Full Text] [Related]
32. Tardive dyskinesia, clozapine, and treatment response.
Dalack GW; Becks L; Meador-Woodruff JH
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):567-73. PubMed ID: 9682273
[TBL] [Abstract][Full Text] [Related]
33. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
34. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
35. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
36. Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.
Shim JC; Kim YH; Kelly DL; Lee JG; Conley RR
J Neuropsychiatry Clin Neurosci; 2005; 17(2):221-6. PubMed ID: 15939977
[TBL] [Abstract][Full Text] [Related]
37. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
[TBL] [Abstract][Full Text] [Related]
38. Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.
Pardis P; Remington G; Panda R; Lemez M; Agid O
J Psychopharmacol; 2019 Oct; 33(10):1187-1198. PubMed ID: 31347436
[TBL] [Abstract][Full Text] [Related]
39. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
[TBL] [Abstract][Full Text] [Related]
40. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
